查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702114

感染監測解決方案市場報告，按組件（軟體、服務）、部署類型（本地、基於雲端）、最終用戶（醫院、診所、門診服務中心、專科中心等）和地區分類，2025 年至 2033 年

Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球感染監測解決方案市場規模達 7.025 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 13.639 億美元，2025-2033 年期間的成長率 (CAGR) 為 7.27%。不斷成長的醫療相關感染 (HAI)、防止感染傳播的嚴格監管合規性以及允許自動捕獲患者資料的醫療 IT 的進步是推動市場發展的一些主要因素。

感染監測解決方案是醫療機構採用的綜合系統，用於監測和分析患者群體中感染的流行程度、傳播和影響。他們利用先進的資料收集、整合和分析工具來追蹤和報告各種醫療相關感染（HAI），例如血液感染、手術部位感染和呼吸道感染。由於它們使醫療保健提供者能夠及時發現潛在的疫情爆發、實施有針對性的干涉措施並最終提高患者安全，因此全球對感染監測解決方案的需求正在增加。

目前，人們對包括感染控制在內的患者安全的日益關注正在促進市場的成長。與此相符的是，人們越來越意識到數據驅動決策在醫療保健領域的重要性，這促進了市場的成長。此外，老年族群更容易受到感染，因此對感染監測解決方案的需求不斷成長，這對市場產生了積極影響。此外，用於監測和減輕傳染病爆發的監控解決方案的投資不斷增加，為行業投資者提供了豐厚的成長機會。此外，資料分析、人工智慧 (AI) 和機器學習 (ML) 方面的創新正在增強感染監測解決方案的能力並使其更加高效，從而支持市場的成長。除此之外，全球醫療保健基礎設施的改善也促進了市場的成長。

感染監測解決方案市場趨勢/促進因素：

醫院相關感染（HAI）不斷增加

由於個人醫療保健相關感染 (HAI) 的不斷增加，感染監測解決方案的採用率不斷提高，從而促進了市場的成長。同時，這些感染對患者的健康造成威脅，導致住院時間延長、醫療費用增加，甚至在某些情況下導致死亡。除此之外，減輕這些感染以提高病人安全性的需求也在增加。透過持續監測和分析患者資料，這些解決方案能夠及早發現感染並允許醫療機構及時實施干預。因此，減少醫院感染不僅可以改善病患的治療效果，還可以為醫療機構節省成本。

嚴格遵守法規，防止感染蔓延

在醫療保健行業，遵守監管要求和認證標準至關重要。醫療保險和醫療補助服務中心 (CMS) 和聯合委員會等監管機構正在強制報告和預防醫療相關感染 (HAI)。此外，不遵守規定可能會導致處罰和聲譽損害。除此之外，感染監測解決方案對於確保合規性至關重要。它們有助於準確收集、分析和報告感染率資料，幫助醫療機構有效地滿足監管要求。此外，認證機構將感染控制視為醫療保健品質的關鍵組成部分。此外，醫療保健組織正在投資先進的感染監測系統，這不僅滿足監管需求，而且有助於獲得和維持認證，提高其聲譽和可信度。

醫療保健IT的進步

電子健康記錄 (EHR)、健康資訊交換 (HIE) 和綜合健康系統的日益普及正在推動市場的成長。與此相符的是，感染監測解決方案可以與現有的醫療保健 IT 基礎設施無縫連接，並允許自動捕獲患者資料、實驗室結果和其他相關資訊。這些系統的介面簡化了監控流程並確保了即時資料的可用性以進行分析，這為市場前景帶來了積極的影響。醫療保健專業人員可以快速獲得可操作的見解，有助於及早發現和應對潛在的疫情。此外，這些解決方案和醫療保健 IT 不僅增強了感染控制，而且還提高了醫療保健的整體效率和有效性。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球感染監測解決方案市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：按組成部分

  • 軟體
  • 服務

第7章：市場區隔：依部署類型

  • 本地
  • 基於雲端

第8章：市場區隔：按最終用戶

  • 醫院
  • 診所
  • 門診服務中心
  • 專業中心
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Centrak Inc. (Halma plc)
    • Cerner Corporation
    • CKM Healthcare Incorporated
    • Ecolab Inc.
    • International Business Machines Corporation
    • Medexter Healthcare
    • Perahealth Inc.
    • PointClickCare
    • Premier Inc.
    • Sunquest Information Systems Inc. (Roper Technologies Inc.)
Product Code: SR112025A4857

The global infection surveillance solutions market size reached USD 702.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,363.9 Million by 2033, exhibiting a growth rate (CAGR) of 7.27% during 2025-2033. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

Breakup by Component:

  • Software
  • Services

Software represents the largest market segment

Breakup by Deployment Type:

  • On-premises
  • Cloud-based

On-premises accounts for the majority of the market share

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Service Centers
  • Specialty Centers
  • Others

Hospitals hold the biggest market share

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Baxter International Inc.
  • Becton Dickinson and Company
  • Centrak Inc. (Halma plc)
  • Cerner Corporation
  • CKM Healthcare Incorporated
  • Ecolab Inc.
  • International Business Machines Corporation
  • Medexter Healthcare
  • Perahealth Inc.
  • PointClickCare
  • Premier Inc.
  • Sunquest Information Systems Inc. (Roper Technologies Inc.)

Key Questions Answered in This Report

  • 1.What was the size of the global infection surveillance solutions market in 2024?
  • 2.What is the expected growth rate of the global infection surveillance solutions market during 2025-2033?
  • 3.What are the key factors driving the global infection surveillance solutions market?
  • 4.What has been the impact of COVID-19 on the global infection surveillance solutions market?
  • 5.What is the breakup of the global infection surveillance solutions market based on the component?
  • 6.What is the breakup of the global infection surveillance solutions market based on the deployment type?
  • 7.What is the breakup of the global infection surveillance solutions market based on the end user?
  • 8.What are the key regions in the global infection surveillance solutions market?
  • 9.Who are the key players/companies in the global infection surveillance solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Surveillance Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Service Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Specialty Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Centrak Inc. (Halma plc)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cerner Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 CKM Healthcare Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ecolab Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 International Business Machines Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medexter Healthcare
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perahealth Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 PointClickCare
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Premier Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2024
  • Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
  • Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
  • Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million USD), 2025-2033
  • Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
  • Table 7: Global: Infection Surveillance Solutions Market: Key Players